172 related articles for article (PubMed ID: 15703487)
1. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.
Heinzerling L; Burg G; Dummer R; Maier T; Oberholzer PA; Schultz J; Elzaouk L; Pavlovic J; Moelling K
Hum Gene Ther; 2005 Jan; 16(1):35-48. PubMed ID: 15703487
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.
Triozzi PL; Strong TV; Bucy RP; Allen KO; Carlisle RR; Moore SE; Lobuglio AF; Conry RM
Hum Gene Ther; 2005 Jan; 16(1):91-100. PubMed ID: 15703492
[TBL] [Abstract][Full Text] [Related]
3. Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses.
Müller J; Feige K; Wunderlin P; Hödl A; Meli ML; Seltenhammer M; Grest P; Nicolson L; Schelling C; Heinzerling LM
J Immunother; 2011 Jan; 34(1):58-64. PubMed ID: 21150713
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.
Rochlitz C; Dreno B; Jantscheff P; Cavalli F; Squiban P; Acres B; Baudin M; Escudier B; Heinzerling L; Morant R; Herrmann R; Dietrich PY; Dummer R
Cancer Gene Ther; 2002 Mar; 9(3):289-95. PubMed ID: 11896446
[TBL] [Abstract][Full Text] [Related]
5. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma.
Ridolfi L; Ridolfi R
Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of the intratumoral administration of recombinant canarypox viruses expressing B7.1 and interleukin 12 in patients with metastatic melanoma.
Triozzi PL; Allen KO; Carlisle RR; Craig M; LoBuglio AF; Conry RM
Clin Cancer Res; 2005 Jun; 11(11):4168-75. PubMed ID: 15930353
[TBL] [Abstract][Full Text] [Related]
7. Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.
Kaufman HL; Deraffele G; Mitcham J; Moroziewicz D; Cohen SM; Hurst-Wicker KS; Cheung K; Lee DS; Divito J; Voulo M; Donovan J; Dolan K; Manson K; Panicali D; Wang E; Hörig H; Marincola FM
J Clin Invest; 2005 Jul; 115(7):1903-12. PubMed ID: 15937544
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial.
Mahvi DM; Henry MB; Albertini MR; Weber S; Meredith K; Schalch H; Rakhmilevich A; Hank J; Sondel P
Cancer Gene Ther; 2007 Aug; 14(8):717-23. PubMed ID: 17557109
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
[TBL] [Abstract][Full Text] [Related]
10. Human gene therapy for melanoma: CT-guided interstitial injection.
Waddill W; Wright W; Unger E; Stopeck A; Akporiaye E; Harris D; Grogan T; Schluter S; Hersh E; Stahl S
AJR Am J Roentgenol; 1997 Jul; 169(1):63-7. PubMed ID: 9207502
[TBL] [Abstract][Full Text] [Related]
11. Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients.
Fujii S; Huang S; Fong TC; Ando D; Burrows F; Jolly DJ; Nemunaitis J; Hoon DS
Cancer Gene Ther; 2000 Sep; 7(9):1220-30. PubMed ID: 11023194
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses.
Heinzerling LM; Feige K; Rieder S; Akens MK; Dummer R; Stranzinger G; Moelling K
J Mol Med (Berl); 2001; 78(12):692-702. PubMed ID: 11434722
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.
Khorana AA; Rosenblatt JD; Sahasrabudhe DM; Evans T; Ladrigan M; Marquis D; Rosell K; Whiteside T; Phillippe S; Acres B; Slos P; Squiban P; Ross M; Kendra K
Cancer Gene Ther; 2003 Apr; 10(4):251-9. PubMed ID: 12679797
[TBL] [Abstract][Full Text] [Related]
14. In vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid DNA coding for equine interleukin 12.
Müller JM; Wissemann J; Meli ML; Dasen G; Lutz H; Heinzerling L; Feige K
Schweiz Arch Tierheilkd; 2011 Nov; 153(11):509-13. PubMed ID: 22045456
[TBL] [Abstract][Full Text] [Related]
15. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer.
Walther W; Siegel R; Kobelt D; Knösel T; Dietel M; Bembenek A; Aumann J; Schleef M; Baier R; Stein U; Schlag PM
Clin Cancer Res; 2008 Nov; 14(22):7545-53. PubMed ID: 19010873
[TBL] [Abstract][Full Text] [Related]
16. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma.
Stopeck AT; Jones A; Hersh EM; Thompson JA; Finucane DM; Gutheil JC; Gonzalez R
Clin Cancer Res; 2001 Aug; 7(8):2285-91. PubMed ID: 11489803
[TBL] [Abstract][Full Text] [Related]
18. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
[TBL] [Abstract][Full Text] [Related]
19. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.
Keyser J; Schultz J; Ladell K; Elzaouk L; Heinzerling L; Pavlovic J; Moelling K
Exp Dermatol; 2004 Jun; 13(6):380-90. PubMed ID: 15186325
[TBL] [Abstract][Full Text] [Related]
20. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma.
Butterfield LH; Ribas A; Dissette VB; Amarnani SN; Vu HT; Oseguera D; Wang HJ; Elashoff RM; McBride WH; Mukherji B; Cochran AJ; Glaspy JA; Economou JS
Clin Cancer Res; 2003 Mar; 9(3):998-1008. PubMed ID: 12631598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]